4/11
11:00 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
Low
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
4/11
11:00 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
Low
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
4/11
10:27 am
aplt
Rating for APLT
Low
Report
Rating for APLT
4/11
10:27 am
aplt
Rating for APLT
Low
Report
Rating for APLT
3/26
08:51 am
aplt
Rating for APLT
Medium
Report
Rating for APLT
3/26
08:51 am
aplt
Rating for APLT
Medium
Report
Rating for APLT
3/26
08:44 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $12.00 price target on the stock.
Medium
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $12.00 price target on the stock.
3/26
08:44 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $12.00 price target on the stock.
Medium
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $12.00 price target on the stock.
3/15
08:45 am
aplt
Rating for APLT
High
Report
Rating for APLT
3/6
12:37 pm
aplt
Rating for APLT
Medium
Report
Rating for APLT
2/22
07:38 am
aplt
Rating for APLT
Low
Report
Rating for APLT
2/16
12:06 pm
aplt
Rating for APLT
Medium
Report
Rating for APLT
2/16
12:06 pm
aplt
Rating for APLT
Medium
Report
Rating for APLT